Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view

此次收购增强了本地制造和物流能力，REJURAN化妆品正通过丝芙兰、亚马逊和加拿大市场扩张，并着眼于未来在美洲地区的增长。

SEOUL, South Korea

韩国首尔

,

，

July 1, 2026

2026年7月1日

/PRNewswire/ -- PharmaResearch, the South Korea-based regenerative medicine company behind REJURAN, is strengthening its localization strategy across North America with the planned acquisition of Cosmetic Group USA, a U.S.-based cosmetics manufacturer also known as CG USA.

/美通社/ -- 韩国再生医学公司PharmaResearch（丽珠兰REJURAN的幕后企业）正通过计划收购美国化妆品制造商Cosmetic Group USA（又称CG USA），加强其在北美地区的本地化战略。

PharmaResearch signed an agreement on June 30, local time, to acquire CG USA, a cosmetics OEM and ODM manufacturer, as demand for REJURAN Cosmetics continues to grow in the United States.

随着丽珠兰化妆品在美国的需求持续增长，PharmaResearch于当地时间6月30日签署协议，收购化妆品代工生产商CG USA。

Continue Reading

继续阅读

Representatives from PharmaResearch and CG USA pose for a group photo following the signing of the acquisition agreement.

PharmaResearch 和 CG USA 的代表在签署收购协议后合影留念。

Based in California, CG USA is a cosmetics OEM and ODM manufacturer with capabilities across product planning, formula development, manufacturing, filling, packaging, and quality control. The company holds a cosmetics manufacturing license and operates an FDA-registered facility with a quality management system aligned with current good manufacturing practice, or cGMP, standards.

CG USA 总部位于加利福尼亚州，是一家化妆品 OEM 和 ODM 制造商，具备产品规划、配方研发、生产制造、灌装、包装及质量控制等全方位能力。该公司持有化妆品生产许可证，其工厂已在 FDA 注册，并建立了符合现行药品生产质量管理规范（cGMP）标准的质量管理体系。

Its manufacturing infrastructure also supports production of over-the-counter (OTC) products. .

其制造基础设施也支持非处方药（OTC）产品的生产。

PharmaResearch decided to pursue the acquisition to respond more stably to growing demand for REJURAN Cosmetics, driven in part by its Sephora launch and expanding Amazon channel. Until now, the company has supplied the U.S. market with products manufactured in Korea. Through the acquisition of CG USA, PharmaResearch will secure a local manufacturing base, creating a foundation to improve supply chain efficiency and market responsiveness across production, logistics and distribution. .

PharmaResearch决定推进此次收购，以更稳定地应对REJURAN化妆品日益增长的市场需求，这一需求部分得益于其在丝芙兰（Sephora）的上市以及亚马逊渠道的扩张。此前，该公司向美国市场供应的产品均在韩国生产。通过收购CG USA，PharmaResearch将建立本地化生产基地，为提升生产、物流和分销环节的供应链效率及市场响应能力奠定基础。

Building on this, the company plans to strengthen supply stability in North America while accelerating its localization strategy across the Americas to support future expansion into Canada, broader North America and South America.

在此基础上，公司计划加强北美的供应稳定性，同时加速在整个美洲的本地化战略，以支持未来向加拿大、更广泛的北美地区以及南美的扩张。

REJURAN Cosmetics is PharmaResearch's premium derma cosmetics brand, developed from the company's regenerative medicine technology. Built around DOT™ c-PDRN®, the company's patented cosmetic-grade PDRN ingredient, the brand has expanded its U.S. presence through online and offline retail channels, including Sephora and Amazon.

REJURAN Cosmetics 是 PharmaResearch 旗下的高端皮肤护理化妆品品牌，基于公司的再生医学技术开发而成。该品牌以公司专利的化妆品级 PDRN 成分 DOT™ c-PDRN® 为核心，已通过包括丝芙兰和亚马逊在内的线上及线下零售渠道，扩大其在美国市场的布局。

REJURAN Cosmetics is also scheduled to enter Canada in the second half of the year, adding momentum to PharmaResearch's broader North American expansion. .

REJURAN化妆品也计划于下半年进入加拿大市场，为PharmaResearch在北美地区的更广泛扩张增添动力。

'The acquisition of CG USA is a strategic decision to strengthen supply stability and build a stronger foundation for business expansion in North America,' said Ji Hoon Sohn, CEO of PharmaResearch. 'Through this acquisition, PharmaResearch will secure a local production base to support its growth in North America, while also gaining the potential to expand its ODM business in the U.S.

PharmaResearch首席执行官孙志勋表示：“收购CG USA是一项战略决策，旨在加强供应稳定性，并为在北美地区的业务拓展奠定更坚实的基础。通过此次收购，PharmaResearch将建立本地生产基地，以支持其在北美地区的增长，同时还将获得在美国扩展ODM业务的潜力。”

over the mid to long term.' .

在中长期内。

Sohn added, 'CG USA's FDA-registered facility and OTC production capabilities make this acquisition meaningful not only for cosmetics, but also as a foundation for expanding into over-the-counter production. Based on local production capabilities and quality infrastructure, we will continue to strengthen the competitiveness of our global derma cosmetics business.' .

Sohn补充道：“CG USA拥有经美国食品药品监督管理局（FDA）注册的工厂和非处方药（OTC）生产能力，这使得此次收购不仅对化妆品业务具有重要意义，也为拓展非处方药生产奠定了基础。我们将依托本地化生产能力和质量基础设施，持续增强全球皮肤美容业务的竞争力。”

A CG USA representative said, 'We are pleased to partner with PharmaResearch at an important stage in the growth of REJURAN Cosmetics. We look forward to supporting the brand's expansion by bringing together CG USA's manufacturing capabilities and PharmaResearch's expertise.'

CG USA 的一位代表表示：“我们很高兴在 REJURAN Cosmetics 发展的重要阶段与 PharmaResearch 合作。我们期待通过整合 CG USA 的制造能力与 PharmaResearch 的专业知识，支持该品牌的扩张。”

Cosmo Group Inc. advised on the acquisition. Financial terms were not disclosed.

Cosmo Group Inc. 就此次收购提供了顾问服务。财务条款未予披露。

About PharmaResearch:

关于PharmaResearch：

PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. Its diverse portfolio includes medicines, medical devices, cosmetics, and health supplements, all leveraging the core ingredients - DOT™ PDRN and DOT™ PN - which are protected by multiple patents. PharmaResearch is headquartered in Gangneung-si, Gangwon-do, South Korea, and has a U.S.

PharmaResearch 是一家开创性的生物制药公司，致力于通过再生医学提升人类生活质量。其多元化的产品组合包括药品、医疗器械、化妆品和健康补充剂，均依托于受多项专利保护的核心成分——DOT™ PDRN 和 DOT™ PN。PharmaResearch 总部位于韩国江原道江陵市，并在美国设有分支机构。

subsidiary located in Costa Mesa, California, United States. .

位于美国加利福尼亚州科斯塔梅萨的子公司。

Learn more at

了解更多，请访问

https://pharmaresearch.com/en/

https://pharmaresearch.com/zh/

About CG USA:

关于CG美国：

CG USA, Cosmetic Group USA, is a Los Angeles-based cosmetics and personal care product development and manufacturing company founded in 1986. With a one-stop production system spanning research and development, manufacturing, filling and packaging, the company provides OEM and ODM services to global brands.

CG USA（Cosmetic Group USA）是一家总部位于洛杉矶的化妆品及个人护理产品研发与制造企业，成立于1986年。凭借涵盖研发、生产、灌装及包装的一站式生产体系，该公司为全球品牌提供OEM和ODM服务。

CG USA operates an FDA-registered facility and holds ISO 22716 certification. Based on a quality management system aligned with cGMP standards, the company has the manufacturing capabilities to produce over-the-counter, or OTC, products. .

CG USA 运营着一家在美国食品药品监督管理局（FDA）注册的设施，并持有 ISO 22716 认证。基于符合现行药品生产质量管理规范（cGMP）标准的质量管理体系，该公司具备生产非处方药（OTC）产品的制造能力。

*cGMP: A pharmaceutical manufacturing and quality management system that complies with U.S. FDA regulations.

*cGMP：一种符合美国食品药品监督管理局（FDA）法规的药品生产和质量管理体系。

SOURCE PharmaResearch

来源：PharmaResearch

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示